The Food and Drug Administration (FDA) declined on Friday to approve MDMA-assisted psychotherapy as a treatment for post-traumatic stress disorder (PTSD). The agency has asked Lykos Therapeutics, ...

When the Food and Drug Administration (FDA) declined to approve MDMA-assisted psychotherapy as a treatment for post-traumatic stress disorder (PTSD) last year, the details of its objections were not ...

"Hearst Magazines and Yahoo may earn commission or revenue on some items through these links." On Friday, the Food and Drug Administration (FDA) refused to approve midomafetamine (MDMA) for the ...

A decades-long campaign to legalize MDMA as a mainstream medical treatment will reach a climax as soon as Friday, with the Food and Drug Administration poised to decide whether the psychedelic should ...

Efforts to make MDMA legally available as a psychotherapeutic catalyst hit a daunting roadblock in August. The Food and Drug Administration (FDA) declined to approve a new drug application submitted ...

Lykos Therapeutics, the drug’s manufacturer, said the agency requested an additional phase 3 clinical trial to study the drug’s safety and efficacy, according to an Aug. 9 news release from the ...

We’re honored to welcome Bruce Sewick, LCPC, CADC, a nationally respected educator and clinician, for a powerful presentation on MDMA-assisted psychotherapy and its transformative potential for ...

MDMA-assisted psychotherapy is demonstrating to be promising for PTSD. Source: Activedia/Pixabay, Creative Commons In recent years, MDMA-assisted psychotherapy has been highlighted as a breakthrough ...

Overall, 86 percent of participants who received MDMA combined with psychotherapy saw symptoms subside, and 71 percent no longer met criteria for PTSD by the study's end. That's compared to 48% of ...

(Reuters) - Combining intensive psychotherapy with a pure form of the party drug ecstasy is safe and could aid recovery in people with post-traumatic stress disorder (PTSD), according to the findings ...